Comparison of Carboplatin Plus Pemetrexed Followed by Maintenance Pemetrexed With Docetaxel Monotherapy in Elderly Patients With Advanced Nonsquamous Non–Small Cell Lung CancerIsamu Okamoto, Kazuhiko Nakagawa, Atsushi Horiike et al.|JAMA Oncology|2020Cited by 67
Randomized Phase III Study of Continuation Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: COMPASS (WJOG5610L)Takashi Seto, Yoichi Nakanishi, Koichi Azuma et al.|Journal of Clinical Oncology|2019Cited by 43
First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*Miyako Satouchi, Katsuyuki Hotta, Kaname Nosaki et al.|Cancer Science|2021Cited by 18
Randomized phase III study comparing carboplatin plus pemetrexed followed by pemetrexed versus docetaxel in elderly patients with advanced non-squamous non-small-cell lung cancer (JCOG1210/WJOG7813L).Isamu Okamoto, Kazuhiko Nakagawa, Hiroshi Nokihara et al.|Journal of Clinical Oncology|2019Cited by 8
Prevalence of NTRK gene fusions in a large cohort of Japanese patients with lung cancerAtsushi Nakamura, Kōichi Goto, Hibiki Udagawa et al.|Annals of Oncology|2017Cited by 3